142 related articles for article (PubMed ID: 14976713)
21. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests.
Rando DG; Doriguetto AC; Tomich de Paula da Silva CH; Ellena J; Sato DN; Leite CQ; Varanda EA; Ferreira EI
Eur J Med Chem; 2006 Oct; 41(10):1196-200. PubMed ID: 16828526
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.
Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2012 Oct; 56():387-95. PubMed ID: 22907036
[TBL] [Abstract][Full Text] [Related]
23. Antimycobacterial N-pyridinylsalicylamides, isosters of salicylamides.
Waisser K; Drazková K; Kunes J; Klimesová V; Kaustová J
Farmaco; 2004 Aug; 59(8):615-25. PubMed ID: 15262531
[TBL] [Abstract][Full Text] [Related]
24. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
Bergmann KE; Cynamon MH; Welch JT
J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
[TBL] [Abstract][Full Text] [Related]
25. Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
Krátký M; Janďourek O; Baranyai Z; Novotná E; Stolaříková J; Bősze S; Vinšová J
Eur J Med Chem; 2019 Nov; 181():111578. PubMed ID: 31401536
[TBL] [Abstract][Full Text] [Related]
26. N1-Hetaryl substituted pyridine- and pyrazinecarboxamidrazones with antimycobacterial activity.
Ranft D; Lehwark-Yvetot G; Schaper KJ; Büge A
Arch Pharm (Weinheim); 1997 Jun; 330(6):169-72. PubMed ID: 9297448
[TBL] [Abstract][Full Text] [Related]
27. Antimycobacterial activity of natural and semi-synthetic lignans.
Silva ML; Martins CH; Lucarini R; Sato DN; Pavanb FR; Freitas NH; Andrade LN; Pereira AC; Bianco TN; Vinholis AH; Cunha WR; Bastos JK; Silva R; Da Silva Filho AA
Z Naturforsch C J Biosci; 2009; 64(11-12):779-84. PubMed ID: 20158145
[TBL] [Abstract][Full Text] [Related]
28. New antimycobacterial 2,3-dihydro-1-alkylindole-2-thiones.
Waisser K; Heinisch L; Slosárek M; Janota J
Folia Microbiol (Praha); 2006; 51(1):25-6. PubMed ID: 16821707
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives.
Klimesová V; Zahajská L; Waisser K; Kaustová J; Möllmann U
Farmaco; 2004 Apr; 59(4):279-88. PubMed ID: 15081345
[TBL] [Abstract][Full Text] [Related]
31. Diethyl 2-(phenylcarbamoyl)phenyl phosphorothioates: synthesis, antimycobacterial activity and cholinesterase inhibition.
Vinšová J; Krátký M; Komlóová M; Dadapeer E; Stěpánková S; Vorčáková K; Stolaříková J
Molecules; 2014 May; 19(6):7152-68. PubMed ID: 24886941
[TBL] [Abstract][Full Text] [Related]
32. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
Adamec J; Waisser K; Kunes J; Kaustová J
Arch Pharm (Weinheim); 2005 Aug; 338(8):385-9. PubMed ID: 16041837
[TBL] [Abstract][Full Text] [Related]
33. New series of isoniazid hydrazones linked with electron-withdrawing substituents.
Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J
Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides.
Servusová B; Vobicková J; Paterová P; Kubíček V; Kuneš J; Doležal M; Zitko J
Bioorg Med Chem Lett; 2013 Jun; 23(12):3589-91. PubMed ID: 23659859
[TBL] [Abstract][Full Text] [Related]
36. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Foroumadi A; Soltani F
Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
[TBL] [Abstract][Full Text] [Related]
37. Heterocyclic benzazole derivatives with antimycobacterial in vitro activity.
Kocí J; Klimesová V; Waisser K; Kaustová J; Dahse HM; Möllmann U
Bioorg Med Chem Lett; 2002 Nov; 12(22):3275-8. PubMed ID: 12392731
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and local anesthetic activity--lipophilicity relationships for a homological series of phenylcarbamic acid esters. Note II.
Gregán F; Svec P; Kettmann V; Sivý J
Farmaco; 1996 Oct; 51(10):669-72. PubMed ID: 8981758
[TBL] [Abstract][Full Text] [Related]
39. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
40. High active potential antimycobacterial agents against Mycobacterium avium.
Karel W; Jiří K; Jiřina S
Ceska Slov Farm; 2012 Jun; 61(3):127-9. PubMed ID: 22913828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]